Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<p>This is a monthly version of our HK Connect Weekly note, in which I highlight Hong Kong-listed companies leading the southbound flow weekly. Over the past month, we have seen the flow turned from outflow in February to inflow in March. Chinese investors were also buying Consumer Staples and Consumer Discretionary stocks.</p><h2>Our March Coverage of Hong Kong Connect southbound flow</h2><ul>
<li><a href="https://www.smartkarma.com/insights/hk-connect-discovery-weekly-picc-xinyi-solar-2019-03-08" target="_blank">HK Connect Discovery Weekly: PICC, Xinyi Solar (2019-03-08)</a></li>
<li><a href="https://www.smartkarma.com/insights/hk-connect-discovery-weekly-eligibility-adjustment-2019-03-15" target="_blank">HK Connect Discovery Weekly: Eligibility Adjustment (2019-03-15)</a></li>
<li><a href="https://www.smartkarma.com/insights/hk-connect-discovery-weekly-mainland-investors-buying-wh-group-2019-03-22" target="_blank">HK Connect Discovery Weekly: Mainland Investors Buying WH Group (2019-03-22)</a></li>
</ul>

This is a monthly version of our HK Connect Weekly note, in which I highlight Hong Kong-listed companies leading the southbound flow weekly. Over the past month, we have seen the flow turned from outflow in February to inflow in March. Chinese investors were also buying Consumer Staples and Consumer Discretionary stocks.Our March Coverage of Hong Kong Connect southbound flow
HK Connect Discovery Weekly: PICC, Xinyi Solar (2019-03-08)
HK Connect Discovery Weekly: Eligibility Adjustment (2019-03-15)
HK Connect Discovery Weekly: Mainland Investors Buying WH Group (2019-03-22)


HK Connect Discovery - March Snapshot (WH Group, Air China)

China

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and markets bulk pharmaceuticals, preparations, and chemical products.  Bulk pharmaceutical products include antipyretic, analgesic, antiseptic, and central nervous system medicines.

Shandong Xinhua Pharmaceutical Company (719 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

HK Connect Discovery - March Snapshot (WH Group, Air China)

This is a monthly version of our HK Connect Weekly note, in which I highlight Hong Kong-listed companies leading the southbound flow weekly. Over...

Ke Yan, CFA, FRM